标题
Intraperitoneal immunotherapy: historical perspectives and modern therapy
作者
关键词
-
出版物
CANCER GENE THERAPY
Volume 23, Issue 11, Pages 373-381
出版商
Springer Nature
发表日期
2016-11-11
DOI
10.1038/cgt.2016.49
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Spontaneous regression of tumour and the role of microbial infection – possibilities for cancer treatment
- (2016) Petra Kucerova et al. ANTI-CANCER DRUGS
- Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic delivery
- (2016) S C Katz et al. CANCER GENE THERAPY
- Augmentation of Immune Checkpoint Cancer Immunotherapy with IL18
- (2016) Z. Ma et al. CLINICAL CANCER RESEARCH
- Reversing T-cell Dysfunction and Exhaustion in Cancer
- (2016) H. M. Zarour CLINICAL CANCER RESEARCH
- Natural killer cells stimulated with PM21 particles expand and biodistribute in vivo: Clinical implications for cancer treatment
- (2016) Jeremiah L. Oyer et al. CYTOTHERAPY
- The role of regional chemotherapy in the management of extremity soft tissue malignancies
- (2016) H.G. Smith et al. EJSO
- L1 Cell Adhesion Molecule-Specific Chimeric Antigen Receptor-Redirected Human T Cells Exhibit Specific and Efficient Antitumor Activity against Human Ovarian Cancer in Mice
- (2016) Hao Hong et al. PLoS One
- Evolving Immunotherapy Approaches for Renal Cell Carcinoma
- (2016) Susanna A. Curtis et al. Current Oncology Reports
- Resectability of Peritoneal Carcinomatosis: Learnings from a Prospective Cohort of 533 Consecutive Patients Selected for Cytoreductive Surgery
- (2015) Kayvan Mohkam et al. ANNALS OF SURGICAL ONCOLOGY
- Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T
- (2015) Rachel A. Burga et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases
- (2015) S. C. Katz et al. CLINICAL CANCER RESEARCH
- Incidence and treatment of recurrent disease after cytoreductive surgery and intraperitoneal chemotherapy for peritoneally metastasized colorectal cancer: A systematic review
- (2015) T.R. van Oudheusden et al. EJSO
- Beyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint Regulators
- (2015) Isabelle Le Mercier et al. Frontiers in Immunology
- IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumorsin vivo
- (2015) Mythili Koneru et al. OncoImmunology
- Treatment of gastric peritoneal carcinomatosis by combining complete surgical resection of lesions and intraperitoneal immunotherapy using catumaxomab
- (2014) Diane Goéré et al. BMC CANCER
- Cancer Immunotherapy and Breaking Immune Tolerance: New Approaches to an Old Challenge
- (2014) A. Makkouk et al. CANCER RESEARCH
- Surgical management of bowel obstruction in patients with peritoneal carcinomatosis
- (2014) Bahbak Shariat-Madar et al. JOURNAL OF SURGICAL ONCOLOGY
- Peritoneal carcinomatosis of gastrointestinal tumors: Where are we now?
- (2014) Cem Terzi WORLD JOURNAL OF GASTROENTEROLOGY
- Impact of peritoneal carcinomatosis in the disease history of colorectal cancer management: a longitudinal experience of 2406 patients over two decades
- (2013) A G Kerscher et al. BRITISH JOURNAL OF CANCER
- Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model
- (2013) Melissa A. Geller et al. CYTOTHERAPY
- Immunotherapy for solid tumors—a review for surgeons
- (2013) Abdul Saied et al. JOURNAL OF SURGICAL RESEARCH
- Multifaceted Therapeutic Targeting of Ovarian Peritoneal Carcinomatosis Through Virus-induced Immunomodulation
- (2013) Shashi Gujar et al. MOLECULAR THERAPY
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
- (2013) Stephan A. Grupp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Surgical Outcomes of Hyperthermic Intraperitoneal Chemotherapy
- (2013) Mehraneh D. Jafari et al. JAMA Surgery
- Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone
- (2012) P. Wimberger et al. ANNALS OF ONCOLOGY
- Early- and Long-Term Outcome Data of Patients With Pseudomyxoma Peritonei From Appendiceal Origin Treated by a Strategy of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
- (2012) Terence C. Chua et al. JOURNAL OF CLINICAL ONCOLOGY
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
- (2012) Cecele J. Denman et al. PLoS One
- Novel Monoclonal Antibodies for Cancer Treatment: The Trifunctional Antibody Catumaxomab (Removab®)
- (2012) Diane Seimetz Journal of Cancer
- Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response
- (2011) Yu-Li Chen et al. Molecular Oncology
- Oncolytic Virus-initiated Protective Immunity Against Prostate Cancer
- (2011) Shashi A Gujar et al. MOLECULAR THERAPY
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial
- (2010) Markus M. Heiss et al. INTERNATIONAL JOURNAL OF CANCER
- Reovirus Virotherapy Overrides Tumor Antigen Presentation Evasion and Promotes Protective Antitumor Immunity
- (2010) S. A. Gujar et al. MOLECULAR CANCER THERAPEUTICS
- T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
- (2010) Maria R Parkhurst et al. MOLECULAR THERAPY
- Safety and immunologic effects of IL-15 administration in nonhuman primates
- (2009) C. Berger et al. BLOOD
- Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
- (2009) H. Fujisaki et al. CANCER RESEARCH
- Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival
- (2009) Mark J. Dobrzanski et al. CLINICAL IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started